CRIM2 Inhibitors
CRIM2 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the Cysteine-Rich Intestinal Protein 2 (CRIM2). CRIM2, encoded by the CRIM2 gene, plays a crucial role in cellular processes such as cell adhesion, growth, and migration. These inhibitors work by binding to the active or regulatory sites of the CRIM2 protein, thereby hindering its normal function. This inhibition can occur through various mechanisms, including the alteration of the protein's conformation, blocking the protein's interaction with other cellular partners, or by interfering with its signaling pathways. The development and identification of these inhibitors are grounded on an understanding of CRIM2's structure and its involvement in specific biological processes. The precise interaction between CRIM2 inhibitors and the protein must be characterized by a high degree of specificity to ensure that the inhibition is effective without affecting other proteins that may have similar structures or functions.
The inhibition of CRIM2 by these chemical compounds has significant implications for the modulation of the biological pathways in which CRIM2 is involved. Since CRIM2 is implicated in the regulation of various cellular events, its inhibitors can alter the downstream effects of CRIM2 activity, such as cell-cell interactions and signaling cascades that contribute to the maintenance of tissue integrity. The specificity of CRIM2 inhibitors is critical; these compounds are structurally crafted to interact uniquely with CRIM2, ensuring minimal off-target effects. The research into CRIM2 inhibitors is driven by the protein's role in fundamental cellular functions, and the development of these inhibitors involves meticulous studies of CRIM2's interactions at the molecular level. By focusing on these interactions, scientists can design inhibitors that can precisely disrupt CRIM2's activity, providing a tool to explore the protein's function in greater detail and to elucidate the complex networks of cellular signaling in which CRIM2 is a participant.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
PI-103 is a potent inhibitor of phosphoinositide 3-kinases (PI3Ks) which are upstream regulators of the AKT signaling pathway. CRIM2 function is related to cellular adhesion and migration, processes that can be negatively impacted by altered PI3K/AKT signaling. Therefore, PI-103 through its inhibition of PI3K could lead to a reduction in CRIM2-mediated cellular processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor which functions similar to PI-103. By inhibiting PI3K, LY294002 suppresses AKT phosphorylation and activation, potentially leading to decreased CRIM2 activity due to the integral role of PI3K/AKT pathway in cell migration and survival. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK), which is part of the MAPK/ERK pathway. Since CRIM2 has roles in cellular adhesion and migration, which may be influenced by ERK signaling, PD98059 could indirectly affect CRIM2 activity by inhibiting this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK, a protein kinase involved in the response to stress and inflammatory cytokines. Inhibition of p38 MAPK may result in altered cell migration and adhesion, processes in which CRIM2 is implicated, thus potentially decreasing CRIM2 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is involved in the control of cell proliferation and apoptosis. Because CRIM2 is associated with cell adhesion, inhibiting JNK could lead to reduced CRIM2 functionality in these processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a steroidal fungal metabolite that serves as a potent inhibitor of PI3K. By inhibiting PI3K, Wortmannin could diminish AKT signaling, potentially decreasing the activity of CRIM2 as it may rely on proper PI3K/AKT signaling for its function in cell adhesion and migration. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor which affects cell growth and proliferation. Given CRIM2's potential involvement in these processes, inhibition of mTOR signaling by Rapamycin could lead to reduced CRIM2 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of the Rho-associated protein kinase (ROCK), which plays a significant role in cell motility and structure. Inhibition of ROCK could impair cellular processes that involve CRIM2, thus indirectly decreasing its activity. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC 23766 is an inhibitor of Rac1, a GTPase that is important in the regulation of cell migration. CRIM2's function in cell adhesion and migration could be compromised by inhibiting Rac1, leading to an indirect reduction in CRIM2 activity. | ||||||
BMS-345541 | 445430-58-0 | sc-221741 | 1 mg | $312.00 | 1 | |
BMS-345541 is a selective inhibitor of the IκB kinase (IKK), which regulates NF-κB signaling. By inhibiting IKK and thus NF-κB activity, which can influence cell adhesion and survival, CRIM2-linked processes could be indirectly inhibited. | ||||||